INNOVATIVE EYEWEAR INC (LUCY)
US45791D1090 - Common Stock
LUCY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for LUCY as it has an excellent financial health rating, but there are worries on the profitability. LUCY is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year LUCY has reported negative net income.
In the past year LUCY has reported a negative cash flow from operations.
LUCY had negative earnings in each of the past 5 years.
LUCY had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of LUCY (-100.07%) is worse than 83.42% of its industry peers.
LUCY has a Return On Equity of -107.09%. This is in the lower half of the industry: LUCY underperforms 67.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -100.07% | ||
| ROE | -107.09% | ||
| ROIC | N/A |
ROA(3y)-207.79%
ROA(5y)N/A
ROE(3y)-601.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for LUCY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LUCY has less shares outstanding
There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
LUCY has an Altman-Z score of 6.41. This indicates that LUCY is financially healthy and has little risk of bankruptcy at the moment.
LUCY has a Altman-Z score of 6.41. This is amongst the best in the industry. LUCY outperforms 82.35% of its industry peers.
There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.41 |
ROIC/WACCN/A
WACC9.06%
2.3 Liquidity
A Current Ratio of 14.73 indicates that LUCY has no problem at all paying its short term obligations.
LUCY has a Current ratio of 14.73. This is amongst the best in the industry. LUCY outperforms 98.40% of its industry peers.
LUCY has a Quick Ratio of 12.85. This indicates that LUCY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 12.85, LUCY belongs to the best of the industry, outperforming 98.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 14.73 | ||
| Quick Ratio | 12.85 |
3. Growth
3.1 Past
LUCY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1259.10%.
Looking at the last year, LUCY shows a very strong growth in Revenue. The Revenue has grown by 188.64%.
Measured over the past years, LUCY shows a very strong growth in Revenue. The Revenue has been growing by 167.81% on average per year.
EPS 1Y (TTM)-1259.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1143.94%
Revenue 1Y (TTM)188.64%
Revenue growth 3Y167.81%
Revenue growth 5YN/A
Sales Q2Q%81.58%
3.2 Future
Based on estimates for the next years, LUCY will show a very strong growth in Earnings Per Share. The EPS will grow by 29.10% on average per year.
Based on estimates for the next years, LUCY will show a very strong growth in Revenue. The Revenue will grow by 347.21% on average per year.
EPS Next Y35%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year457.14%
Revenue Next 2Y347.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LUCY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as LUCY's earnings are expected to grow with 29.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3YN/A
5. Dividend
5.1 Amount
LUCY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INNOVATIVE EYEWEAR INC
NASDAQ:LUCY (11/22/2024, 8:00:00 PM)
6.56
-0.16 (-2.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.30M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -100.07% | ||
| ROE | -107.09% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 14.73 | ||
| Quick Ratio | 12.85 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1259.1%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y35%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)188.64%
Revenue growth 3Y167.81%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y